D. Yellon
Cardiology and Cardiovascular Medicine · 2002–2019
A researcher in the Science corpus: 13 papers; trusts 1 researcher and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 35 citations into it; #63 of 906 by trust here, #263 by citations
- Pathology and Forensic Medicine — 29 citations into it; #8 of 414 by trust here, #67 by citations
- Molecular Biology — 28 citations into it; #6,720 of 17,773 by trust here, #9,476 by citations
Whom D. Yellon trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts D. Yellon overall
- G. Heusch
- Jay L. Zweier
- E. Murphy
- D. Hausenloy
- Theodore J Kalogeris
- M. A. Talukder
- S. Cadenas
- C. Steenbergen
- A. Tsang
- Christopher P. Baines
Papers from D. Yellon's perspective
Ordered by how strongly the researchers D. Yellon trusts endorse each paper. Same corpus, a different order for every researcher.
- Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. (Cardiovascular Research)
- Cyclosporine before PCI in Patients with Acute Myocardial Infarction. (New England Journal of Medicine)
- Preconditioning the myocardium: from cellular physiology to clinical cardiology. (Physiological Reviews)
- ERRATA (Nature Medicine)
- Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. (Circulation)
- Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning (Pharmacological Reviews)
- A 40 kDa protein of the inner membrane is the mitochondrial calcium uniporter (Nature)
- Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. (The Lancet)
- Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) (Critical Care)
- Serine/threonine protein kinases and apoptosis. (Experimental Cell Research)
Their papers
- Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury (2010) — 946 citations
- New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. (2004) — 1,088 citations
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target. (2013) — 2,190 citations
- Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? (2002) — 644 citations
- De novo cardiomyocytes from within the activated adult heart after injury (2011) — 648 citations
- Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. (2005) — 632 citations
- Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (2019) — 641 citations
- Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. (2015) — 696 citations
- Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure (2014) — 664 citations
- Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. (2007) — 694 citations
- Myocardial reperfusion injury. (2007) — 1,907 citations
- Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway (2004) — 710 citations
- Preconditioning the myocardium: from cellular physiology to clinical cardiology. (2003) — 1,145 citations